GRAND RAPIDS, Mich. (WOOD) — The CEO of GW Pharmaceuticals, which developed the first cannabis-based medication to win federal approval, visited Grand Rapids this week to speak to health experts on the Medical Mile.
The U.S. Food and Drug Administration last year approved Epidiolex to treat severe childhood-onset epilepsy.
There's more to read on WOODTV.com